Selective inhibition of breast cancer stem cells by gold nanorods mediated plasmonic hyperthermia

Biomaterials

Volumn 35, Issue 16, 2014, Pages 4667-4677

  Xu, Yingying ^a   Wang, Jing ^a   Li, Xiaofan ^a   Liu, Ying ^a   Dai, Luru ^a   Wu, Xiaochun ^a   Chen, Chunying ^a  

^a NATIONAL CENTER FOR NANOSCIENCE AND TECHNOLOGY   (China)

Author keywords

ALDH; Cancer stem cells; Gold nanorods; Mammosphere; Photothermal

Indexed keywords

CELL CULTURE; CELL PROLIFERATION; CHEMOTHERAPY; DISEASES; DRUG DELIVERY; GENE EXPRESSION; GOLD; GOLD COMPOUNDS; GOLD NANORODS; NANORODS; ONCOLOGY; PLASMONICS; POLYELECTROLYTES; STEM CELLS;

ALDEHYDE DEHYDROGENASE; ALDH; CANCER STEM CELLS; COMBINATORIAL STRATEGIES; MAMMOSPHERE; MCF-7 BREAST CANCER CELLS; PHOTO-THERMAL; TRIGGERED DRUG RELEASE;

RADIOTHERAPY;

ALDEHYDE DEHYDROGENASE; GOLD; GOLD NANOROD; NANOROD; POLYELECTROLYTE; SALINOMYCIN; UNCLASSIFIED DRUG;

ARTICLE; BREAST CANCER; CANCER STEM CELL; CANCER THERAPY; CELL POPULATION; DRUG RELEASE; GENE EXPRESSION; HUMAN; HUMAN CELL; HYPERTHERMIA; PRIORITY JOURNAL;

ALDH; CANCER STEM CELLS; GOLD NANORODS; MAMMOSPHERE; PHOTOTHERMAL;

ALDEHYDE DEHYDROGENASE; BREAST NEOPLASMS; CELL LINE, TUMOR; FEMALE; GOLD; HUMANS; HYPERTHERMIA, INDUCED; NANOTUBES; NEOPLASTIC STEM CELLS; PHOTOTHERAPY; PYRANS;

EID: 84896543534     PISSN: 01429612     EISSN: 18785905     Source Type: Journal    
DOI: 10.1016/j.biomaterials.2014.02.035     Document Type: Article

References (40)

1. Vargo-Gogola T., Rosen J.M. Modelling breast cancer: one size does not fit all. Nat Rev Cancer 2007, 7:659-672.
2. Berry D.A., Cronin K.A., Plevritis S.K., Fryback D.G., Clarke L., Zelen M., et al. Effect of screening and adjuvant therapy on mortality from breast cancer. NEngl J Med 2005, 353:1784-1792.
3. Al-Hajj M., Wicha M.S., Benito-Hernandez A., Morrison S.J., Clarke M.F. Prospective identification of tumorigenic breast cancer cells. Proc Natl Acad Sci U S A 2003, 100:3983-3988.
4. Singh S.K., Clarke I.D., Terasaki M., Bonn V.E., Hawkins C., Squire J., et al. Identification of a cancer stem cell in human brain tumors. Cancer Res 2003, 63:5821-5828.
5. Stingl J., Caldas C. Molecular heterogeneity of breast carcinomas and the cancer stem cell hypothesis. Nat Rev Cancer 2007, 7:791-799.
6. Chen J., Li Y.J., Yu T.S., McKay R.M., Burns D.K., Kernie S.G., et al. Arestricted cell population propagates glioblastoma growth after chemotherapy. Nature 2012, 488:522-526.
7. Dalerba P., Cho R.W., Clarke M.F. Cancer stem cells: models and concepts. Ann Rev Med 2007, 58:267-284.
8. Jiang W.J., Peng J.H., Zhang Y., Cho W.C.S., Jin K.L. The implications of cancer stem cells for cancer therapy. Int J Mol Sci 2012, 13:16636-16657.
9. Li X.X., Lewis M.T., Huang J., Gutierrez C., Osborne C.K., Wu M.F., et al. Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. JNatl Cancer Inst 2008, 100:672-679.
10. Dean M., Fojo T., Bates S. Tumour stem cells and drug resistance. Nat Rev Cancer 2005, 5:275-284.
11. Gangemi R., Paleari L., Orengo A.M., Cesario A., Chessa L., Ferrini S., et al. Cancer stem cells: a new paradigm for understanding tumor growth and progression and drug resistance. Curr Med Chem 2009, 16:1688-1703.
12. Gupta P.B., Onder T.T., Jiang G.Z., Tao K., Kuperwasser C., Weinberg R.A., et al. Identification of selective inhibitors of cancer stem cells by high-throughput screening. Cell 2009, 138:645-659.
13. Cobley C.M., Chen J.Y., Cho E.C., Wang L.V., Xia Y.N. Gold nanostructures: a class of multifunctional materials for biomedical applications. Chem Soc Rev 2011, 40:44-56.
14. Zhang Z.J., Wang J., Chen C.Y. Near-infrared light-mediated nanoplatforms for cancer thermo-chemotherapy and optical imaging. Adv Mater 2013, 25:3869-3880.
15. Chen H.J., Shao L., Li Q., Wang J.F. Gold nanorods and their plasmonic properties. Chem Soc Rev 2013, 42:2679-2724.
16. Wang J., Dong B., Chen B.T., Jiang Z.L., Song H.W. Selective photothermal therapy for breast cancer with targeting peptide modified gold nanorods. Dalt Trans 2012, 41:11134-11144.
17. Huang X.H., El-Sayed I.H., Qian W., El-Sayed M.A. Cancer cell imaging and photothermal therapy in the near-infrared region by using gold nanorods. JAm Chem Soc 2006, 128:2115-2120.
18. Tang J.L., Jiang X.M., Wang L.M., Zhang H., Hu Z.J., Liu Y., et al. Au@Pt nanostructure: a novel photothermal conversion agent for cancer therapy. Nanoscale 2014, 10.1039/C3NR06841B.
19. Zhang Z.J., Wang L.M., Wang J., Jiang X.M., Li X.H., Hu Z.J., et al. Mesoporous silica-coated gold nanorods as a light-mediated multifunctional theranostic platform for cancer treatment. Adv Mater 2012, 24:1418-1423.
20. Alkilany A.M., Thompson L.B., Boulos S.P., Sisco P.N., Murphy C.J. Gold nanorods: their potential for photothermal therapeutics and drug delivery, tempered by the complexity of their biological interactions. Adv Drug Deliv Rev 2012, 64:190-199.
21. Wang L.M., Liu Y., Li W., Jiang X.M., Ji Y.L., Wu X.C., et al. Selective targeting of gold nanorods at the mitochondria of cancer cells: implications for cancer therapy. Nano Lett 2011, 11:772-780.
22. Burke A.R., Singh R.N., Carroll D.L., Wood J.C.S., D'Agostino R.B., Ajayan P.M., et al. The resistance of breast cancer stem cells to conventional hyperthermia and their sensitivity to nanoparticle-mediated photothermal therapy. Biomaterials 2012, 33:2961-2970.
23. Atkinson R.L., Zhang M., Diagaradjane P., Peddibhotla S., Contreras A., Hilsenbeck S.G., et al. Thermal enhancement with optically activated gold nanoshells sensitizes breast cancer stem cells to radiation therapy. Sci Transl Med 2010, 2:55ra79. (1-10).
24. Lee E., Hong Y., Choi J., Haam S., Suh J.S., Huh Y.M., et al. Highly selective CD44-specific gold nanorods for photothermal ablation of tumorigenic subpopulations generated in MCF7 mammospheres. Nanotechnology 2012, 23:465101. p. 8.
25. Qiu Y., Liu Y., Wang L.M., Xu L.G., Bai R., Ji Y.L., et al. Surface chemistry and aspect ratio mediated cellular uptake of Au nanorods. Biomaterials 2010, 31:7606-7619.
26. Sau T.K., Murphy C.J. Seeded high yield synthesis of short Au nanorods in aqueous solution. Langmuir 2004, 20:6414-6420.
27. Gole A., Murphy C.J. Polyelectrolyte-coated gold nanorods: synthesis, characterization and immobilization. Chem Mater 2005, 17:1325-1330.
28. Kuo T.R., Hovhannisyan V.A., Chao Y.C., Chao S.L., Chiang S.J., Lin S.J., et al. Multiple release kinetics of targeted drug from gold nanorod embedded polyelectrolyte conjugates induced by near-infrared laser irradiation. JAm Chem Soc 2010, 132:14163-14171.
29. Ginestier C., Hur M.H., Charafe-Jauffret E., Monville F., Dutcher J., Brown M., et al. ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell 2007, 1:555-567.
30. Hirata N., Sekino Y., Kanda Y. Nicotine increases cancer stem cell population in MCF-7 cells. Biochem Biophys Res Commun 2010, 403:138-143.
31. Hwang-Verslues W.W., Kuo W.H., Chang P.H., Pan C.C., Wang H.H., Tsai S.T., et al. Multiple lineages of human breast cancer stem/progenitor cells identified by profiling with stem cell markers. Plos One 2009, 4:e8377. (1-11).
32. Dontu G., Abdallah W.M., Foley J.M., Jackson K.W., Clarke M.F., Kawamura M.J., et al. Invitro propagation and transcriptional profiling of human mammary stem/progenitor cells. Genes Dev 2003, 17:1253-1270.
33. Yu F., Li J., Chen H., Fu J., Ray S., Huang S., et al. Kruppel-like factor 4 (KLF4) is required for maintenance of breast cancer stem cells and for cell migration and invasion. Oncogene 2011, 30:2161-2172.
34. Aydin R.S. Herceptin-decorated salinomycin-loaded nanoparticles for breast tumor targeting. JBiomed Mater Res A 2013, 101:1405-1415.
35. Zhi Q.M., Chen X.H., Ji J., Zhang J.N., Li J.F., Cai Q., et al. Salinomycin can effectively kill ALDH (high) stem-like cells on gastric cancer. Biomed Pharmacother 2011, 65:509-515.
36. Dong T.T., Zhou H.M., Wang L.L., Feng B., Lv B., Zheng M.H. Salinomycin selectively targets 'CD133+' cell subpopulations and decreases malignant traits in colorectal cancer lines. Ann Surg Oncol 2011, 18:1797-1804.
37. Morrison B.J., Schmidt C.W., Lakhani S.R., Reynolds B.A., Lopez J.A. Breast cancer stem cells: implications for therapy of breast cancer. Breast Cancer Res 2008, 10:210. (1-14).
38. Charafe-Jauffret E., Ginestier C., Birnbaum D. Breast cancer stem cells: tools and models to rely on. BMC Cancer 2009, 9:201. (1-10).
39. Palaniyandi K., Pockaj B.A., Gendler S.J., Chang X.B. Human breast cancer stem cells have significantly higher rate of clathrin-independent and caveolin-independent endocytosis than the differentiated breast cancer cells. JCancer Sci Ther 2012, 4:214-222.
40. Xiao Y.L., Hong H., Matson V.Z., Javadi A., Xu W., Yang Y.A., et al. Gold nanorods conjugated with doxorubicin and cRGD for combined anticancer drug delivery and PET imaging. Theranostics 2012, 2:757-768.